Publications by authors named "Jan Eucker"

Claim this Profile
E
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study.
Susanne Klein-Scory, Alexander Baraniskin, Wolff Schmiegel, Thomas Mika, Roland Schroers, Jan Eucker

Mol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of BYL-719 (alpelisib) on human breast cancer stem cells to overcome drug resistance in human breast cancer.
Leinan Yu, Chuanbing Zang, Yuanchun Ye, Hongyu Liu, Jan Eucker

Front Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
Sebastian Stintzing, Kathrin Heinrich, David Tougeron, Dominik Paul Modest, Ingo Schwaner, Jan Eucker

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancer.
Markus S Anker, Alessia Lena, Eric J Roeland, Jan Porthun, Sebastian Schmitz, Jan Eucker

J Cachexia Sarcopenia Muscle· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
Yuanchun Ye, Ouyang Ge, Chuanbing Zang, Leina Yu, Jan Eucker

Technol Cancer Res Treat· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Non-Sustained Ventricular Tachycardia and Premature Ventricular Contractions and Their Prognostic Relevance in Patients with Cancer in Routine Care.
Annemarie Albrecht, Jan Porthun, Jan Eucker, Andrew J S Coats, Stephan von Haehling

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study.
Markus S Anker, Stephan von Haehling, Andrew J S Coats, Hanno Riess, Jan Eucker

Eur J Heart Fail· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
Annekathrin Reinhardt, Hongyu Liu, Yunxia Ma, Yongan Zhou, Chuanbing Zang, Jan Eucker

Anticancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors.
Frederik Marmé, Carlos Gomez-Roca, Kristina Graudenz, Funan Huang, John Lettieri, Jan Eucker

Cancer Chemother Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed release of chemokine CCL25 with bioresorbable microparticles for mobilization of human mesenchymal stem cells.
Kristin Fröhlich, David Hartzke, Franziska Schmidt, Jan Eucker, Aleksander Gurlo

Acta Biomater· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions.
Berit Maria Müller, Elke Keil, Annika Lehmann, Klaus-Jürgen Winzer, Christiane Richter-Ehrenstein, Jan Eucker

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Chemotherapy on the Antioxidant Status of Human Skin.
Bich Na Lee, Sora Jung, Maxim E Darvin, Jan Eucker, Dagmar Kühnhardt

Anticancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer.
Chuanbing Zang, Jan Eucker, Piet Habbel, Christian Neumann, Carsten-Oliver Schulz

Cell Cycle· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin Plus Ifosfamide with/without Etoposide as Salvage Treatment in Heavily-pre-treated Patients with Metastatic Breast Cancer.
Piet Habbel, Annika Kurreck, Carsten-Oliver Schulz, Anne Constanze Regierer, David Kaul, Jan Eucker

Anticancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TKI258, a multi-tyrosine kinase inhibitor is efficacious against human infant/childhood lymphoblastic leukemia in vitro.
Jan Eucker, Chuanbing Zang, Yongan Zhou, Xinhua Li, Piet Habbel

Anticancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The multi-tyrosine kinase inhibitor TKI258, alone or in combination with RAD001, is effective for treatment of human leukemia with BCR-ABL translocation in vitro.
Jan Eucker, Chuanbing Zang, Yongan Zhou, Xinhua Li, Piet Habbel

Anticancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse differentiation as a gene filtering tool in genome expression profiling of adipogenesis for fat marker gene selection and their analysis.
Mujib Ullah, Stefan Stich, Thomas Häupl, Jan Eucker, Michael Sittinger

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma.
Chuanbing Zang, Jan Eucker, Hongyu Liu, Annekatrin Coordes, Minoo Lenarz

Leuk Lymphoma· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
Chuanbing Zang, Jan Eucker, Hongyu Liu, Anja Müller, Kurt Possinger

Cancer Lett· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.
Mujib Ullah, Jan Eucker, Michael Sittinger, Jochen Ringe

Stem Cell Res Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer.
Jennifer Karle, Juliane Bolbrinker, Silvia Vogl, Reinhold Kreutz, Carsten Denkert, Jan Eucker

Breast Cancer Res Treat· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas.
Agnieszka Korfel, Thomas Elter, Eckhard Thiel, Matthias Hänel, Robert Möhle, Jan Eucker

Haematologica· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdifferentiation of mesenchymal stem cells-derived adipogenic-differentiated cells into osteogenic- or chondrogenic-differentiated cells proceeds via dedifferentiation and have a correlation with cell cycle arresting and driving genes.
Mujib Ullah, Stefan Stich, Michael Notter, Jan Eucker, Michael Sittinger

Differentiation· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mTOR inhibitor everolimus in combination with carboplatin in metastatic breast cancer--a phase I trial.
Sandra Schwarzlose-Schwarck, Christian W Scholz, Anne C Regierer, Peter Martus, Christian Neumann, Jan Eucker

Anticancer Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Hongyu Liu, Christian Scholz, Chuanbing Zang, Jan H Schefe, Piet Habbel, Jan Eucker

Anticancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis